Literature DB >> 10933414

Plasma fibrinogen of black South Africans: the BRISK study.

H H Vorster1, J C Jerling, K Steyn, C J Badenhorst, W Slazus, C S Venter, P L Jooste, L T Bourne.   

Abstract

OBJECTIVE: To describe the distribution of plasma fibrinogen and relationships with other risk factors for coronary heart disease (CHD) and stroke in the black population of the Cape Peninsula.
DESIGN: A cross-sectional survey of a stratified proportional sample of randomly selected black men and women.
SETTING: Households in Gugulethu, Langa, Nyanga, New Crossroads, KTC, Old Crossroads and Khayelitsha in the Cape Peninsula, South Africa.
SUBJECTS: One subject per household (352 men and 447 women), aged 15-64 years, voluntarily participated. Visitors, pregnant, lactating, ill, mentally retarded and intoxicated subjects were excluded.
RESULTS: Mean fibrinogen (thrombin time coagulation method) of men and women were higher than published data for Europeans but slightly lower than values of black Americans. Women aged 45-54 years had the highest level (3.13+/-0.89 g l(-1)) and men aged 15-24 years had the lowest (2.13+/-0.88 g l(-1)). Fifteen per cent of the men and 12% of the women had a level greater than 1 standard deviation of the mean for their age group. Univariate and multivariate analyses revealed significant (P<0.05) positive correlations of fibrinogen with smoking habit, age, body mass index (BMI), total and low-density lipoprotein (LDL) cholesterol, triglycerides, blood pressure and white blood cell count, and significant negative correlations with high-density lipoprotein (HDL) cholesterol, gamma glutamyl transferase (GGT), serum iron and ferritin. The correlations with BMI, serum lipoproteins, iron, ferritin, and GGT suggest that nutritional status and therefore diet influences plasma fibrinogen.
CONCLUSION: Relatively high fibrinogen levels, tending to cluster with other, including diet-related, risk factors for CHD and stroke, were observed in black South Africans. It is suggested that fibrinogen may contribute to the high stroke incidence of this population group.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10933414     DOI: 10.1079/phn19980026

Source DB:  PubMed          Journal:  Public Health Nutr        ISSN: 1368-9800            Impact factor:   4.022


  4 in total

Review 1.  A comprehensive view of sex-specific issues related to cardiovascular disease.

Authors:  Louise Pilote; Kaberi Dasgupta; Veena Guru; Karin H Humphries; Jennifer McGrath; Colleen Norris; Doreen Rabi; Johanne Tremblay; Arsham Alamian; Tracie Barnett; Jafna Cox; William Amin Ghali; Sherry Grace; Pavel Hamet; Teresa Ho; Susan Kirkland; Marie Lambert; Danielle Libersan; Jennifer O'Loughlin; Gilles Paradis; Milan Petrovich; Vicky Tagalakis
Journal:  CMAJ       Date:  2007-03-13       Impact factor: 8.262

2.  The impact of gender and peripheral blood parameters on the characteristics of L-PRF membranes.

Authors:  Catherine Andrade Aldana; Felipe Ugarte Amenabar; Carolina Inostroza Silva; Paulo Diaz Calderon; David Rosenberg Messina; Nelson Pinto Carrasco; Marc Quirynen
Journal:  J Oral Biol Craniofac Res       Date:  2022-09-01

3.  Is HIV-1 infection associated with endothelial dysfunction in a population of African ancestry in South Africa?

Authors:  C Fourie; J van Rooyen; M Pieters; K Conradie; T Hoekstra; A Schutte
Journal:  Cardiovasc J Afr       Date:  2011 May-Jun       Impact factor: 1.167

4.  Differences in thrombin and plasmin generation potential between East African and Western European adults: The role of genetic and non-genetic factors.

Authors:  Godfrey S Temba; Nadira Vadaq; Jun Wan; Vesla Kullaya; Dana Huskens; Tal Pecht; Martin Jaeger; Collins K Boahen; Vasiliki Matzaraki; Wieteke Broeders; Leo A B Joosten; Sultana M H Faradz; Gibson Kibiki; Saskia Middeldorp; Duccio Cavalieri; Paolo Lionetti; Philip G de Groot; Joachim L Schultze; Mihai G Netea; Vinod Kumar; Bas de Laat; Blandina T Mmbaga; Andre J van der Ven; Mark Roest; Quirijn de Mast
Journal:  J Thromb Haemost       Date:  2022-02-10       Impact factor: 16.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.